Complete Filing Data
Bain Capital Specialty Finance, Inc. reported Investment Company Dividend Distribution of $126.49 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bain Capital Specialty Finance, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | $98.8M | $119.4M | $123.4M | $105.5M | $119.8M | $8.3M |
| Other General And Administrative Expense | $8.4M | $10.1M | $8.0M | $5.8M | $5.0M | $5.4M |
| Interest Expense | $80.6M | $74.7M | $80.0M | $52.3M | $51.3M | $63.3M |
| Income Taxes Paid Net | $3.3M | $2.2M | $834.0K | $134.0K | $237.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $27.8M | $18.7M | $23.7M | $28.5M | $22.1M | $33.1M | $29.1M | $35.1M | $31.1M | $33.9M | $29.2M | $29.3M | $43.5M | $11.1M | $17.2M | $33.7M | $22.3M | $23.3M | $42.4M | $31.8M | $39.5M | $51.5M | $21.8M | -$104.4M |
| Other General And Administrative Expense | $2.0M | $1.9M | $2.6M | $2.5M | $2.5M | $2.4M | $2.2M | $1.5M | $1.7M | $1.4M | $1.5M | $1.4M | $1.4M | |||||||||||
| Interest Expense | $20.3M | $21.8M | $18.9M | $18.1M | $17.6M | $18.1M | $20.8M | $20.5M | $19.6M | $14.4M | $11.0M | $10.6M | $12.3M | |||||||||||
| Income Taxes Paid Net | $3.3M | $2.2M | $834.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.12B | $1.14B | $1.14B | $1.12B | $1.10B | $1.07B | $1.02B | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $58.9M | $99.1M | $112.5M | $125.7M | $203.6M | $81.7M | $68.8M | |||
| Assets Net | $1.12B | $1.14B | $1.14B | $1.12B | $1.10B | $1.07B | $1.02B | $1.00B | $507.0M | $110.3M |
| Stockholders Equity Period Increase Decrease | -$22.3M | $3.2M | $20.1M | $16.4M | $32.0M | $49.6M | ||||
| Cash Held In Foreign Currency | $3.2M | $2.0M | $6.4M | $29.6M | $30.0M | $972.0K | ||||
| Restricted Cash | $32.7M | $45.5M | $63.1M | $66.0M | $86.2M | $27.0M | ||||
| Amortization Of Debt Discount Premium | -$5.2M | -$5.1M | -$5.3M | -$4.9M | -$5.7M | -$5.9M | ||||
| Repayments Of Long Term Debt | $1.23B | $735.3M | $480.0M | $462.2M | $1.46B | $710.8M | ||||
| Debt And Equity Securities Unrealized Gain Loss | $21.6M | -$12.3M | $29.5M | -$10.7M | $16.0M | -$28.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$42.4M | -$12.8M | -$12.2M | -$78.5M | $126.9M | $12.9M | ||||
| Cash | $23.1M | $51.6M | $43.0M | $30.2M | $87.4M | |||||
| Restricted Cash And Cash Equivalents | $32.7M | $45.5M | $63.1M | $66.0M | $86.2M | |||||
| Receivable Investment Sale | $28.9M | $37.8M | $4.3M | $18.2M | $30.3M | |||||
| Payable Investment Purchase | $2.1M | $29.5M | $11.5M | $34.3M | $7.6M | |||||
| Management Fee Payable | $9.4M | $9.2M | $8.9M | $8.9M | $8.8M | |||||
| Liabilities And Stockholders Equity | $2.66B | $2.63B | $2.47B | $2.59B | $2.57B | |||||
| Incentive Fee Payable | $5.9M | $4.7M | $7.3M | $9.2M | $4.7M | |||||
| Dividends Receivable | $5.4M | $5.7M | $9.4M | $13.7M | $18.4M | |||||
| Distribution Payable | $9.7M | $29.1M | $27.1M | $23.2M | $22.0M | |||||
| Deferred Offering Costs | $3.5M | $4.6M | $2.8M | $3.7M | $2.2M | |||||
| Deferred Finance Costs Net | $10.1M | $4.9M | $7.6M | $10.2M | $15.7M | |||||
| Common Stock Value | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.13B | $1.14B | $1.14B | $1.15B | $1.14B | $1.14B | $1.13B | $1.13B | $1.12B | $1.10B | $1.11B | $1.11B | $1.10B | $1.10B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $86.8M | $174.5M | $94.0M | $59.8M | $98.1M | $122.5M | $105.4M | $128.6M | $81.1M | $58.8M | $68.9M | $114.8M | $92.9M | |
| Assets Net | $1.13B | $1.14B | $1.14B | $1.15B | $1.14B | $1.14B | $1.13B | $1.13B | $1.12B | $1.10B | $1.1M | $1.1M | ||
| Stockholders Equity Period Increase Decrease | -$10.5M | -$5.5M | $4.8M | $4.0M | $37.0K | $6.0M | $6.7M | $4.6M | $4.8M | -$10.9M | -$4.7M | $11.7M | $1.4M | |
| Cash Held In Foreign Currency | $19.7M | $9.7M | $28.2M | $5.1M | $12.7M | $2.2M | $14.3M | $4.6M | $6.6M | $11.8M | $24.8M | $829.0K | ||
| Restricted Cash | $26.2M | $136.9M | $55.6M | $29.3M | $67.0M | $73.6M | $25.9M | $36.2M | $51.4M | $14.7M | $25.9M | $34.0M | $57.8M | |
| Amortization Of Debt Discount Premium | -$1.6M | -$1.5M | -$1.8M | $176.0K | -$1.5M | |||||||||
| Repayments Of Long Term Debt | $395.7M | $97.0M | $133.0M | $16.0M | ||||||||||
| Debt And Equity Securities Unrealized Gain Loss | $24.7M | -$3.8M | $10.4M | $7.8M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.3M | $10.2M | -$44.2M | -$86.9M | ||||||||||
| Cash | $40.9M | $27.8M | $10.2M | $25.3M | $18.4M | $46.7M | $65.2M | $87.7M | $23.1M | $32.3M | ||||
| Restricted Cash And Cash Equivalents | $26.2M | $136.9M | $55.6M | $29.3M | $67.0M | $73.6M | $25.9M | $36.2M | $51.4M | $14.7M | ||||
| Receivable Investment Sale | $29.2M | $34.0M | $32.2M | $17.9M | $24.2M | $2.4M | $2.8M | $95.9M | $50.7M | $109.2M | ||||
| Payable Investment Purchase | $2.7M | $4.5M | $1.9M | $17.3M | $27.3M | $8.8M | $3.2M | $233.0K | $15.0M | $17.7M | ||||
| Management Fee Payable | $9.4M | $9.3M | $9.1M | $8.9M | $8.8M | $8.8M | $9.1M | $9.1M | $8.8M | $8.8M | ||||
| Liabilities And Stockholders Equity | $2.72B | $2.77B | $2.64B | $2.54B | $2.41B | $2.58B | $2.57B | $2.68B | $2.61B | $2.52B | ||||
| Incentive Fee Payable | $4.6M | $5.4M | $2.2M | $7.0M | $7.9M | $9.2M | $3.0M | $4.0M | $11.1M | $3.0M | ||||
| Dividends Receivable | $4.1M | $3.7M | $6.1M | $8.7M | $7.3M | $6.9M | $13.3M | $13.8M | $17.7M | $10.4M | ||||
| Distribution Payable | $0.00 | $0.00 | $0.00 | $29.1M | $29.1M | $29.1M | $27.1M | $24.5M | $24.5M | $22.0M | ||||
| Deferred Offering Costs | $3.8M | $4.1M | $4.3M | $4.9M | $5.1M | $2.6M | $3.0M | $3.3M | $3.5M | $3.7M | ||||
| Deferred Finance Costs Net | $11.2M | $11.5M | $12.6M | $5.6M | $6.3M | $6.9M | $8.2M | $8.9M | $9.5M | $10.9M | ||||
| Common Stock Value | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K | $65.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Proceeds From Issuance Of Long Term Debt | $1.31B | $867.0M | $348.0M | $792.7M | $1.43B | $597.3M |
| Proceeds From Disposition Of Investment Operating Activity | $1.24B | $1.49B | $937.6M | $988.1M | $1.40B | $538.5M |
| Payments For Purchase Of Investment Operating Activity | $1.31B | $1.63B | $844.3M | $1.40B | $1.18B | $516.2M |
| Net Cash Provided By Used In Operating Activities | $29.5M | -$27.1M | $219.3M | -$316.8M | $265.6M | $89.4M |
| Net Cash Provided By Used In Financing Activities | -$71.9M | $14.3M | -$231.4M | $238.3M | -$138.6M | -$76.5M |
| Increase Decrease In Receivable For Investment Sold | $33.9M | $26.2M | $22.8M | $15.0M | $10.8M | $8.8M |
| Increase Decrease In Management Fee Payable | $248.0K | $231.0K | $23.0K | $114.0K | $2.5M | -$976.0K |
| Increase Decrease In Interest Payable Net | -$1.5M | $577.0K | $1.2M | $5.1M | -$1.2M | -$7.3M |
| Increase Decrease In Incentive Fee Payable | $1.2M | -$2.6M | -$1.9M | $4.5M | $928.0K | -$714.0K |
| Increase Decrease In Dividends Receivable | -$391.0K | -$3.7M | -$4.3M | -$4.7M | $10.8M | $6.6M |
| Increase Decrease In Derivative Assets | $1.2M | $2.1M | -$2.0M | $6.8M | -$2.1M | $4.9M |
| Increase Decrease In Accrued Interest Receivable Net | -$1.1M | $2.0M | $2.9M | $15.0M | $3.5M | -$6.8M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.9M | $5.2M | $6.6M | -$943.0K | $636.0K | $996.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.2M | -$571.0K | -$1.1M | $649.0K | -$5.0M | -$45.0K |
| Increase Decrease In Prepaid Expense | $292.0K | -$13.0K | $16.0K | $1.0K | $193.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Long Term Debt | $459.0M | $198.0M | $155.0M | $55.0M |
| Proceeds From Disposition Of Investment Operating Activity | $251.3M | $296.7M | $252.9M | $111.5M |
| Payments For Purchase Of Investment Operating Activity | $299.4M | $400.9M | $327.2M | $241.8M |
| Net Cash Provided By Used In Operating Activities | -$7.3M | -$63.7M | -$43.0M | -$101.8M |
| Net Cash Provided By Used In Financing Activities | $2.0M | $73.9M | -$1.2M | $14.9M |
| Increase Decrease In Receivable For Investment Sold | $5.4M | $4.3M | $4.2M | $3.9M |
| Increase Decrease In Management Fee Payable | -$92.0K | -$111.0K | -$86.0K | -$423.0K |
| Increase Decrease In Interest Payable Net | -$2.3M | -$396.0K | $1.9M | $591.0K |
| Increase Decrease In Incentive Fee Payable | -$2.5M | $1.9M | $1.9M | -$1.4M |
| Increase Decrease In Dividends Receivable | $338.0K | -$2.5M | $4.0M | -$11.9M |
| Increase Decrease In Derivative Assets | -$6.9M | $440.0K | -$4.8M | -$2.2M |
| Increase Decrease In Accrued Interest Receivable Net | -$8.1M | -$7.1M | -$2.3M | $1.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $980.0K | -$322.0K | -$120.0K | -$1.6M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $186.0K | -$185.0K | -$446.0K | -$1.9M |
| Increase Decrease In Prepaid Expense | -$197.0K | $544.0K | -$179.0K | -$178.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $17.23 | $17.65 | $17.60 | $17.29 | $17.04 | $16.54 | $19.72 | $19.46 | $20.30 | $20.10 |
| Earnings Per Share Basic | $1.53 | $1.85 | $1.91 | $1.63 | $1.86 | $0.14 | ||||
| Earnings Per Share Diluted | $1.53 | $1.85 | $1.91 | $1.63 | $1.86 | $0.14 | ||||
| Investment Company Investment Income Loss Per Share | $1.88 | $2.09 | $2.19 | $1.59 | $1.36 | $1.46 | $1.64 | $1.45 | $0.73 | $-0.90 |
| Weighted Average Number Of Shares Outstanding Basic | 64.8M | 64.6M | 64.6M | 64.6M | 64.6M | 58.7M | ||||
| Common Stock Shares Outstanding | 64.9M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 64.8M | 64.6M | 64.6M | 64.6M | 64.6M | 58.7M | ||||
| Common Stock Shares Issued | 64.9M | 64.6M | 64.6M | 64.6M | 64.6M | |||||
| Common Stock Shares Authorized | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | ||||||||||||||||||||||||
| Earnings Per Share Basic | $0.43 | $0.29 | $0.37 | $0.44 | $0.34 | $0.51 | $0.45 | $0.55 | $0.48 | $0.52 | $0.45 | $0.45 | $0.67 | $0.17 | $0.27 | $0.52 | $0.35 | $0.36 | $0.66 | $0.49 | $0.61 | $0.80 | $0.40 | $-2.02 |
| Earnings Per Share Diluted | $0.43 | $0.29 | $0.37 | $0.44 | $0.34 | $0.51 | $0.45 | $0.55 | $0.48 | $0.52 | $0.45 | $0.45 | $0.67 | $0.17 | $0.27 | $0.52 | $0.35 | $0.36 | $0.66 | $0.49 | $0.61 | $0.80 | $0.40 | $-2.02 |
| Investment Company Investment Income Loss Per Share | $0.45 | $0.47 | $0.50 | $0.53 | $0.51 | $0.53 | $0.55 | $0.60 | $0.50 | $0.47 | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 64.9M | 64.9M | 64.7M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | |||||||||||
| Common Stock Shares Outstanding | 64.9M | 64.9M | 64.9M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | |||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 64.9M | 64.9M | 64.7M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | ||||||||||||||
| Common Stock Shares Issued | 64.9M | 64.9M | 64.9M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | 64.6M | ||||||||||||||
| Common Stock Shares Authorized | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B | 100.00B |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $126.5M | $116.2M | $103.3M | $89.1M | $87.8M | $87.0M |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$22.8M | -$15.3M | -$18.2M | $2.8M | $32.1M | -$77.6M |
| Net Investment Income | $125.3M | $139.2M | $145.0M | $103.5M | $87.9M | $86.1M |
| Investment Income Operating After Expense And Tax | $121.6M | $134.7M | $141.6M | $102.7M | $87.7M | $85.8M |
| Gross Investment Income Operating | $273.2M | $292.7M | $297.8M | $219.5M | $197.4M | $194.5M |
| Investment Income Operating Tax Expense Benefit | $3.8M | $4.5M | $3.4M | $837.0K | $134.0K | $232.0K |
| Unrealized Gain Loss On Derivatives | -$12.6M | $5.8M | -$2.3M | -$5.3M | $27.9M | -$22.4M |
| Unrealized Gain Loss Investment And Derivative Operating After Tax | $10.4M | -$6.8M | $31.2M | -$19.6M | $43.0M | -$50.3M |
| Realized Gain Loss Investment And Derivative Operating After Tax | -$33.3M | -$8.5M | -$49.4M | $22.4M | -$10.9M | -$27.2M |
| Professional Fees | $2.9M | $3.5M | $2.6M | $3.0M | $2.9M | $2.6M |
| Management Fee Expense | $37.2M | $35.6M | $36.1M | $34.7M | $34.9M | $35.2M |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $147.9M | $153.5M | $152.8M | $116.0M | $109.5M | $108.4M |
| Investment Company Distribution Ordinary Income | $126.5M | $116.2M | $103.3M | $89.1M | $87.8M | $87.0M |
| Incentive Fee Expense | $18.1M | $28.9M | $25.5M | $19.6M | $24.0M | $4.5M |
| Foreign Currency Transaction Gain Loss Realized | $761.0K | -$320.0K | -$5.1M | $5.3M | -$3.5M | $130.0K |
| Gain Loss On Sale Of Derivatives | -$5.8M | $2.3M | -$407.0K | $20.9M | -$23.8M | $6.5M |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $1.4M | -$251.0K | $4.1M | -$3.6M | -$936.0K | |
| Foreign Currency Transaction Gain Loss Unrealized Excluding Investment Price Change Before Tax | $1.4M | -$251.0K | $4.1M | -$3.6M | -$936.0K | $108.0K |
| Noninterest Expense Directors Fees | $720.0K | $695.0K | $716.0K | $707.0K | $725.0K | |
| Realized Investment Gains Losses | -$28.2M | -$10.4M | -$43.9M | -$3.1M | $21.2M | -$33.8M |
| Interest Paid Net | $76.9M | $70.1M | $75.3M | $43.4M | $46.8M | $67.9M |
| Amortization Of Financing Costs | $5.2M | $4.0M | $3.6M | $3.9M | $5.7M | $2.7M |
| Prepaid Insurance | $489.0K | $197.0K | $210.0K | $194.0K | $193.0K | |
| Investment Owned At Cost | $2.50B | $2.45B | $2.30B | $2.42B | $2.31B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Company Dividend Distribution | $29.2M | $29.2M | $29.2M | $29.1M | $29.1M | $29.1M | $27.1M | $24.5M | $24.5M | $22.0M | $22.0M | $22.0M | $22.0M | |||||||||||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$1.9M | -$10.5M | -$6.9M | -$3.6M | -$11.5M | -$888.0K | -$4.0M | $1.1M | -$3.8M | -$1.8M | -$9.7M | -$2.9M | $19.3M | -$19.1M | -$9.5M | $12.0M | $391.0K | $1.6M | $20.5M | $9.6M | $17.6M | $30.0M | $1.8M | -$126.9M |
| Net Investment Income | $30.5M | $30.0M | $31.7M | $33.2M | $34.9M | $35.0M | $34.3M | $35.0M | $35.9M | $36.3M | $40.0M | $32.8M | $25.0M | $30.1M | $26.7M | $21.7M | $22.0M | $21.8M | $21.9M | $22.2M | $22.1M | $21.5M | $20.0M | $22.5M |
| Investment Income Operating After Expense And Tax | $29.7M | $29.2M | $30.6M | $32.1M | $33.6M | $34.0M | $33.1M | $34.0M | $34.9M | $35.6M | $38.9M | $32.2M | $24.2M | $30.1M | $26.7M | $21.7M | $21.9M | $21.8M | $21.9M | $22.2M | $21.9M | $21.5M | $20.0M | $22.5M |
| Gross Investment Income Operating | $68.2M | $67.2M | $71.0M | $66.8M | $73.3M | $72.5M | $72.3M | $74.5M | $74.9M | $72.4M | $75.7M | $74.7M | $62.4M | $58.8M | $52.4M | $46.0M | $51.5M | $49.5M | $46.5M | $49.8M | $48.3M | $46.8M | $47.9M | $51.5M |
| Investment Income Operating Tax Expense Benefit | $800.0K | $801.0K | $1.1M | $1.1M | $1.3M | $1.0M | $1.2M | $1.0M | $1.0M | $640.0K | $1.1M | $595.0K | $837.0K | $134.0K | $232.0K | |||||||||
| Unrealized Gain Loss On Derivatives | $3.0M | -$15.1M | -$2.1M | -$5.7M | $163.0K | $1.2M | $7.1M | -$1.5M | $161.0K | -$2.2M | $8.1M | $1.7M | $6.1M | |||||||||||
| Unrealized Gain Loss Investment And Derivative Operating After Tax | -$80.0K | -$10.2M | $23.0M | -$3.7M | $1.6M | -$2.8M | $50.0M | -$9.2M | $14.4M | -$37.0M | -$12.1M | $9.8M | $7.6M | |||||||||||
| Realized Gain Loss Investment And Derivative Operating After Tax | -$10.4M | $3.3M | -$26.6M | $2.8M | -$5.6M | $3.9M | -$51.8M | -$550.0K | -$17.2M | $18.0M | $2.6M | $2.2M | -$6.0M | |||||||||||
| Professional Fees | $713.0K | $714.0K | $714.0K | $870.0K | $1.0M | $801.0K | $760.0K | $451.0K | $581.0K | $968.0K | $446.0K | $390.0K | $581.0K | |||||||||||
| Management Fee Expense | $9.4M | $9.3M | $9.1M | $8.9M | $8.8M | $8.8M | $9.1M | $9.1M | $8.9M | $8.9M | $8.5M | $8.4M | $8.8M | |||||||||||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $37.2M | $39.3M | $33.7M | $37.5M | $38.0M | $39.5M | $36.1M | $35.7M | $42.0M | $28.7M | $25.6M | $24.3M | $27.8M | |||||||||||
| Investment Company Distribution Ordinary Income | $29.2M | $29.2M | $29.2M | $29.1M | $29.1M | $29.1M | $27.1M | $24.5M | $24.5M | $22.0M | $22.0M | $22.0M | $22.0M | |||||||||||
| Incentive Fee Expense | $4.6M | $5.4M | $2.2M | $7.0M | $7.9M | $9.2M | $3.0M | $4.0M | $11.1M | $3.0M | $4.1M | $3.3M | $4.5M | |||||||||||
| Foreign Currency Transaction Gain Loss Realized | $335.0K | $581.0K | -$249.0K | -$465.0K | -$446.0K | $23.0K | -$673.0K | -$321.0K | -$4.2M | $2.3M | $3.2M | -$488.0K | -$72.0K | |||||||||||
| Gain Loss On Sale Of Derivatives | -$1.0M | -$1.4M | -$2.4M | $20.0K | $169.0K | $1.7M | -$221.0K | $0.00 | -$2.4M | $17.6M | $2.0M | $1.2M | -$2.1M | |||||||||||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$183.0K | $1.5M | $435.0K | $998.0K | $177.0K | -$208.0K | -$279.0K | $127.0K | $3.8M | -$4.8M | -$2.1M | |||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized Excluding Investment Price Change Before Tax | $435.0K | -$208.0K | $3.8M | -$4.8M | $346.0K | -$508.0K | ||||||||||||||||||
| Noninterest Expense Directors Fees | $182.0K | $182.0K | $174.0K | $173.0K | $174.0K | $174.0K | $182.0K | $179.0K | $174.0K | $177.0K | ||||||||||||||
| Realized Investment Gains Losses | -$24.0M | $2.2M | -$10.7M | $1.4M | ||||||||||||||||||||
| Interest Paid Net | $20.0M | $17.6M | $16.8M | $9.0M | ||||||||||||||||||||
| Amortization Of Financing Costs | $1.1M | $890.0K | $880.0K | $1.0M | ||||||||||||||||||||
| Prepaid Insurance | $727.0K | $856.0K | $0.00 | $383.0K | $570.0K | $754.0K | $408.0K | $605.0K | $15.0K | $376.0K | ||||||||||||||
| Investment Owned At Cost | $2.52B | $2.49B | $2.46B | $2.41B | $2.24B | $2.41B | $2.38B | $2.42B | $2.44B | $2.36B |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.